Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.58 USD | -1.76% | -6.04% | -38.60% |
May. 29 | Sector Update: Health Care Stocks Lean Lower Premarket Wednesday | MT |
May. 29 | Cytek Biosciences Gets Approval for Clinical Use of TBNK Reagents in China | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.60% | 746M | |
+6.19% | 215B | |
+10.46% | 187B | |
+18.41% | 143B | |
+29.11% | 110B | |
+1.48% | 64.68B | |
+14.09% | 52.96B | |
+2.69% | 49.84B | |
-4.26% | 38.32B | |
-0.36% | 35.86B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences : Goldman Sachs Starts Cytek Biosciences at Buy With $28 Price Target